PL348156A1 - Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect - Google Patents

Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect

Info

Publication number
PL348156A1
PL348156A1 PL99348156A PL34815699A PL348156A1 PL 348156 A1 PL348156 A1 PL 348156A1 PL 99348156 A PL99348156 A PL 99348156A PL 34815699 A PL34815699 A PL 34815699A PL 348156 A1 PL348156 A1 PL 348156A1
Authority
PL
Poland
Prior art keywords
endowed
pharmaceutical composition
encoding dna
tumor effect
antigenic protein
Prior art date
Application number
PL99348156A
Other languages
English (en)
Inventor
Dino Parente
MASSIMO Anna Maria DI
Santis Rita De
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Publication of PL348156A1 publication Critical patent/PL348156A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001136—Cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL99348156A 1998-10-30 1999-10-18 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect PL348156A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002330A IT1303683B1 (it) 1998-10-30 1998-10-30 Composizione farmaceutiche ad azione antitumorale contenente dnacodificante per frammenti di una proteina antigenica.
PCT/EP1999/007874 WO2000025827A2 (en) 1998-10-30 1999-10-18 Dna molecules encoding muc-1 and use thereof in tumor vaccination

Publications (1)

Publication Number Publication Date
PL348156A1 true PL348156A1 (en) 2002-05-06

Family

ID=11380969

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99348156A PL348156A1 (en) 1998-10-30 1999-10-18 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect

Country Status (19)

Country Link
EP (1) EP1124956A2 (de)
JP (1) JP2002528519A (de)
CN (1) CN1324406A (de)
AR (1) AR020927A1 (de)
AU (1) AU1152200A (de)
BG (1) BG105458A (de)
BR (1) BR9914892A (de)
CA (1) CA2348745A1 (de)
CO (1) CO5231134A1 (de)
CZ (1) CZ20011521A3 (de)
EA (1) EA200100395A1 (de)
HU (1) HUP0103784A2 (de)
IT (1) IT1303683B1 (de)
MX (1) MXPA01004186A (de)
PE (1) PE20001287A1 (de)
PL (1) PL348156A1 (de)
SK (1) SK5712001A3 (de)
TR (1) TR200101141T2 (de)
WO (1) WO2000025827A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548643B1 (en) 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
WO2001057068A1 (en) * 2000-02-01 2001-08-09 The Austin Research Institute Mucin-1 derived antigens and their use in immunotherapy
CA2421751C (en) * 2000-09-11 2014-02-11 Donald W. Kufe Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
WO2002058450A2 (en) 2000-12-22 2002-08-01 Dana-Faber Cancer Institute, Inc. Regulation of cell growth by muc1
CN1791433B (zh) * 2003-03-24 2010-05-26 斯克里普斯研究学院 抗肿瘤生长的dna疫苗及其使用方法
US7696306B2 (en) 2003-07-11 2010-04-13 Board of Agents of the University of Nebraska Compositions and methods for preventing or treating cancer
US8129506B2 (en) 2003-10-24 2012-03-06 Genzyme Corporation Modulation of the interaction of MUC1 with MUC1 ligands
WO2008097844A2 (en) 2007-02-02 2008-08-14 Dana -Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of apoptosis by muc1 and bh3- containing proapoptotic proteins
WO2008097840A2 (en) 2007-02-02 2008-08-14 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of muc1 by hsf1 and stat3
CN106279435B (zh) * 2016-08-16 2019-06-07 新乡医学院 靶向VEGF与mucin1的抗肿瘤疫苗、编码基因、表达载体、表达工程菌及应用
CN114230656A (zh) * 2021-03-24 2022-03-25 深圳市新靶向生物科技有限公司 一种与食道癌驱动基因突变相关的抗原肽组合及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262545B (it) * 1993-10-25 1996-07-02 Menarini Ricerche Sud S P A A Sistema di espressione per linee cellulari eucariotiche
AU727308B2 (en) * 1997-02-24 2000-12-07 Dana-Farber Cancer Institute Recombinant pox virus for immunization against muc1 tumor-associated antigen

Also Published As

Publication number Publication date
MXPA01004186A (es) 2002-06-04
JP2002528519A (ja) 2002-09-03
PE20001287A1 (es) 2000-12-07
AR020927A1 (es) 2002-06-05
CO5231134A1 (es) 2002-12-27
CZ20011521A3 (cs) 2001-10-17
AU1152200A (en) 2000-05-22
TR200101141T2 (tr) 2001-09-21
ITMI982330A1 (it) 2000-04-30
EP1124956A2 (de) 2001-08-22
HUP0103784A2 (hu) 2002-02-28
WO2000025827A3 (en) 2000-08-10
IT1303683B1 (it) 2001-02-23
BG105458A (en) 2002-06-28
EA200100395A1 (ru) 2001-10-22
CA2348745A1 (en) 2000-05-11
CN1324406A (zh) 2001-11-28
WO2000025827A2 (en) 2000-05-11
ITMI982330A0 (it) 1998-10-30
BR9914892A (pt) 2001-07-17
SK5712001A3 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
ZA200110161B (en) Anti-avB3 recombinant human antibodies, nucleic acids encoding same and methods of use.
HUP0001930A3 (en) Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna
IL112453A0 (en) Human repair proteins, dna(rna) encoding them and their preparation
AU2945795A (en) DNA encoding an 18 Kd CDK6 inhibiting protein
PL348156A1 (en) Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect
AU7072896A (en) Dna encoding medicinal proteins
EP1186615A4 (de) PROTEIN UND DAFüR KODIERENDE DNS
AU2003247537A1 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
AU1183200A (en) Novel gene encoding brain-specific membrane protein
EP1220896A4 (de) NEUE HUMANE LIPASEPROTEINE, DAFüR KODIERENDE NUKLEINSäUREN UND DEREN VERWENDUNGEN
AU6181500A (en) Gene encoding novel tsp1-like protein
EP1174503A4 (de) PROTEINE, DAFüR KODIERENDES GEN UND VERFAHREN ZU DEREN VERWENDUNG
EP1142999A4 (de) Protein und dessen dns
AU8953201A (en) A novel polypeptide, a human dna methylation protein and the polynucleotide encoding the polypeptide
EP1111047A4 (de) Protein und dessen dns
EP1409004A4 (de) Isolierte menschliche, ras-ähnliche proteine, diese menschlichen, ras-ähnlichen proteine codierende nukleinsäuremoleküle sowie verwendungen davon
AU2002250273A1 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
GB9824569D0 (en) Virulence gene and protein,and their use
AU2001292769A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
ZA200007318B (en) Particles of HCV envelope proteins: use for vaccination.
AU1183100A (en) Novel ubiquitin-like protein
AU2001288218A1 (en) Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
AU2002250459A8 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
AU2002250348A1 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
IL161944A0 (en) Dna sequence, proteins coded by them, medicaments and detection methods using same